As expected, the hCAP18/LL-37 levels were significantly elevated in the tumor tissue after 1,25(OH)2D3 treatment in a PLC/PRF-5 xenograft tumor (p < 0.01 Fig. 7D). The gene discussed is CAMP; the disease is neoplasm.